Nissen Says Glaxo's Avandia Offers 'No Unique Benefits': Video
269 views · Published 23 March 2012 · 3:52 · Indexed 22 September 2026
Channel: Bloomberg Originals · 2012 · Entertainment
July 14 (Bloomberg) -- Dr. Steven Nissen, chairman of cardiology at the Cleveland Clinic, talks with Margaret Brennan about the risks of GlaxoSmithKline Plc's diabetes drug, Avandia. The Food and Drug Administration is holding a meeting to examine the safety of the drug.
Nissen, talks with Margaret Brennan on Bloomberg Television's "In Business." (Source: Bloomberg)
More from this channel
-
3:30
Market Close 6.4 - Bloomberg
-
0:17
Pens Tie Stanley Cup Series - Bloomberg
-
0:35
Hardware Price Too High - Activision - Bloomberg
-
0:31
FDIC Seeks Citigroup Shares-Up - WSJ - Bloomberg
-
0:44
Bank Have More Accounting Leeway - Bloomberg
-
0:32
Lakers Beat Magic 100-75 - Bloomberg
-
0:30
Johnson Wins 300th Game - Bloomberg
-
1:13
GM Expects To Sell Saturn To Penske Automotive - Bloomberg